Engaging patients in the digital collection of electronic patient-reported outcome measures (ePROMs) and experience measures (ePREMs) is desirable for equitable, patient-centred chronic disease management; however, adherence remain unclear. This study examined demographic and socioeconomic…
Continue Reading
What You Should Know:
– The Centers for Medicare & Medicaid Services (CMS) today issued the 2026 Final Rule that officially codifies the Transforming Episode Accountability Model (TEAM), an innovative new blueprint for tech-enabled, outcome-based…
Continue Reading
Post-discharge management of coronary artery disease (CAD) remains clinically challenging, with digital healthcare’s efficacy underexplored. This study analyzed 16,797 CAD patients enrolled in the HeartMed Digital Management System (June 2018–September 2022), comparing outcomes between…
Continue Reading
Teleflex, a medical technology company, announced that it has finalized its acquisition of the vascular intervention business of Biotronik.In February, Teleflex entered into a definitive agreement with Biotronik to acquire its vascular intervention business…
Continue Reading
A new deep learning model-based tool developed in South Korea can be used to both diagnose coronary artery disease and predict major adverse cardiac events in emergency cases. HOW IT WORKS
Developed by a team of…
The National Heart Centre Singapore is set to pilot a new AI-powered solution for rapid coronary artery disease prediction.SENSE (Singapore Heart Lesion Analyser) is a machine learning-driven system that can automatically interpret heart image scans…
Continue Reading
Background: Cardiac rehabilitation (CR) is effective in preventing cardiovascular diseases; however, participation in CR programs remains limited due to the associated challenges. Integration of wearable devices and real-time monitoring offers a potential solution to…
Continue Reading
Cardiovascular disease (CVD) has stubbornly remained the leading cause of death in the world for over three decades. Many of these deaths are caused by coronary artery disease (CAD), and roughly 21 million American…
Continue Reading
Riverain Technologies’ Global Healthcare Innovation Expands
In a groundbreaking development for medical imaging technology, Riverain Technologies has marked an exceptional year of growth and innovation. The company’s expansion across eight countries in 2024, coupled with…
Choosing optimal revascularization strategies for patients with obstructive coronary artery disease (CAD) remains a clinical challenge. While randomized controlled trials offer population-level insights, gaps remain regarding personalized decision-making for individual patients. We applied off-policy…
Continue Reading
